Investigational Site Number : 643002
Moscow 125412
0 studies enrolling now · 18 studies all time
What they study most
Acute Coronary Syndrome, Asthma, Atherosclerotic Cardiovascular Disease, Colorectal Cancer Metastatic, Fabry Disease, Glycogen Storage Disease Type II, Glycogen Storage Disease Type II (GSD II), Hematological Malignancy, Mucopolysaccharidosis I (MPS I), Non-small Cell Lung Cancer, Ovarian Cancer Recurrent, Pompe Disease
Studies at this site
- Pompe Disease Registry Protocol — Recruiting now
- Mucopolysaccharidosis I (MPS I) Registry — Completed
- Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies — Completed
- Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease — Completed
- Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) — Completed
- Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed
- Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease — Completed
- Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease — Completed
- ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
- Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
- Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen — Completed
- Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients — Completed
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN) — Completed
- An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma — Completed
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
- Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel — Completed
- Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer — Completed
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery — Completed